EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/31/2026
Back to search
Official data from USPTO
INCYTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
INCYTE
ST13
US500000098513070Class
5, 16, 42, 44
Filing
98513070
Registration
7711493
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
08/01/2026
Trademark type
Word
Nice classes
5, 16, 42, 44
Filing date
04/22/2024
Registration date
03/04/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/04/2025
Last transaction
08/01/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/15/2004
First use in commerce
07/15/2004
Drawing code
4
Owner type
03
Owner location
Wilmington, DE, US
Examiner
KOLODNER, LOUIS FRANCIS
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Incyte Holdings Corporation
Representatives
Keith Toms, Esq. McCarter & English, LLP
Technical classification
Nice Classes
Class 5Class 16Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of auto-immune disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders
Class 16
Printed brochuresnewsletterspamphlets in the fields of medical issuesproceduresdisease symptomspatient support and community building
Class 42
Scientific and medical research relating to oncologicalviralhematologicalauto-immunegraft versus hostinflammatorymetabolicmyeloproliferativeskeletal or chondrocyte and dermatological disorders
Class 44
Providing medical information to healthcare providers and patients relating to oncologicalviralhematologicalauto-immunegraft versus hostinflammatorymetabolicmyeloproliferativeskeletal or chondrocyte and dermatological disorders
Publications
History of USPTO decisions and trademark events.
15 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/31/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/31/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/31/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/31/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/31/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/04/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/14/2025
PUBO
PUBLISHED FOR OPPOSITION
01/14/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/08/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/25/2024
DOCK
ASSIGNED TO EXAMINER
10/23/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/10/2024
NWAP
NEW APPLICATION ENTERED
04/22/2024
Continuous trademark protection
Get notified about every new filing that threatens INCYTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.